Back to search

Article

Absence of phosphorylated CDK4, a biomarker of intrinsic resistance to CDK4/6 inhibitors in head and neck squamous cell carcinoma, can be predicted by their gene expression profile

2025-11-11

Abstract excerpt

The level of T172 CDK4 phosphorylation, required for enzyme activity and entry in the normal cell cycle, was variable in two head and neck squamous carcinoma (HNSCC) cohorts, corresponding cell lines and patient-derived tumor xenograft (PDTX) models. Actively proliferating tumors or models lacking CDK4 phosphorylation had defective pRb, elevated E2F1 or CCNE1 expression or were HPV-positive. CDK4 phosphorylation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0755e175-7e8b-5736-bbab-27945dfbced5
DOI
10.1101/2025.11.10.25339594
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Absence of phosphorylated CDK4, a biomarker of intrinsic resistance to CDK4/6 inhibitors in head and neck squamous cell carcinoma, can be predicted by their gene expression profileDOI 10.1101/2025.11.10.25339594
Select a neighboring publication to make it the new centre.